Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Exploring the Link Between Cancer Caregiver Burden and Patient Self Image

      August 21, 2017
      By Katie Kosko
      News
      Article

      In some ways, it’s the down side of optimism: A recent study has found that older people sometimes think they are capable of more activity than their caregivers say they are.

      In some ways, it’s the down side of optimism: A recent study has found that older people sometimes think they are capable of more activity than their caregivers say they are.

      This disconnect can lead to increased burden for caregivers. Researchers from City of Hope National Medical Center in Duarte, California, found that patients view themselves as being more able than their caregivers thought.

      “In daily practice, we sometimes see a disconnect between what the patient perceives their general health and abilities to be in comparison to what the caregiver thinks,” Arti Hurria. M.D., director of Cancer and Aging Research Program and one of the authors on the study, said in a press release. “We wanted to see whether this disconnect impacted caregiver burden.”

      The study examined 100 patients, aged 65 to 91, of which 70 percent had advanced disease. The most common cancers were lymphoma, breast cancer and gastrointestinal cancers.

      Caregivers were mostly women (73 percent) and either the spouse of the patient (68 percent) or an adult child (18 percent). They ranged from 28 to 85 years old.

      Each patient and caregiver independently assessed patient function, comorbidity, nutrition, social activity, social support and mental health. Caregivers also completed the Caregiver Strain Index (CSI), which is a 13-question tool that can help health care workers quickly identify if there are potential caregiving concerns.

      Sixty percent of patients reported requiring help with activities of daily living. Most patients had good social support and mental health.

      Caregivers rated patients as having poorer physical function and mental health. They also reported that patients required more social support. Based on CSI scores, three‐quarters of caregivers experienced some caregiver burden.

      Caregiver burden is commonly perceived as a chronic stressor. Caregivers often experience negative psychological, behavioral and physiological effects on their daily lives and health, according to the National Cancer Institute.

      Researchers said that only the disparity in the assessment of physical function was associated with greater caregiver burden.

      First author, Tina Hsu, M.D., offered two possible explanations for this.

      “One is that older adults with cancer either don’t appreciate how much help they require or, more likely, they are able preserve their sense of independence and dignity through a perception that they feel they can do more than they really can,” she said. “Alternatively, it is possible that caregivers who are more stressed out perceive their loved one to require more help than they actually do need. Most likely, the truth of how much help the patient actually needs lies somewhere between what patients and caregivers report.”

      The researchers plan to explore factors associated with caregiver burden in this population.

      They also advise health care teams to keep lines of communication open and check for caregiver burden in caregivers who report providing more help with instrumental activities of daily living than patients themselves.

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      4 experts in this video
      4 experts in this video
      4 experts in this video
      4 experts in this video
      Image of a woman with light brown hair wearing glasses with a blue background
      Image of a woman wearing glasses in front of a blue background
      Image of a woman with glasses in front of a blue background
      Image of a man in a suit smiling in front of an Oncology Nursing News background
      Related Content

      Photo of the FDA office's sign

      Sunvozertinib Granted FDA Accelerated Approval in EGFR Exon 20+ NSCLC

      Bridget Hoyt
      July 2nd 2025
      Article

      Sunvozertinib has received accelerated approval for use in advanced or metastatic non–small lung cancer harboring EGFR exon 20 insertion mutations.


      The Vitals

      What New Cancer Drugs Were Approved in 2023?

      Lindsay Fischer
      January 1st 2024
      Podcast

      In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.


      Image of a laptop with the words "FDA Food and Drug Adminstration" visible

      Oncology Drugs Approved by the FDA in June

      Bridget Hoyt
      July 2nd 2025
      Article

      Oncologic therapies approved in June included indications in genitourinary, lung, and hematologic, and head and neck cancers.


      The Vitals

      Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

      Lindsay Fischer
      December 14th 2023
      Podcast

      Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.


      Graphic of a pair of lungs with tumors

      ICI Rechallenge With Anlotinib May Benefit Pretreated ES-SCLC

      Roman Fabbricatore
      July 1st 2025
      Article

      Anlotinib combined with immune checkpoint inhibitors may benefit patients with extensive-stage small cell lung cancer treated with prior immunotherapy.


      Photo of a woman with brown hair and bangs, surrounded by a blue border

      AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

      Michelle Kirschner, RN, MSN, ACNP, APRN-BC
      June 30th 2025
      Article

      Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.

      Related Content

      Photo of the FDA office's sign

      Sunvozertinib Granted FDA Accelerated Approval in EGFR Exon 20+ NSCLC

      Bridget Hoyt
      July 2nd 2025
      Article

      Sunvozertinib has received accelerated approval for use in advanced or metastatic non–small lung cancer harboring EGFR exon 20 insertion mutations.


      The Vitals

      What New Cancer Drugs Were Approved in 2023?

      Lindsay Fischer
      January 1st 2024
      Podcast

      In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.


      Image of a laptop with the words "FDA Food and Drug Adminstration" visible

      Oncology Drugs Approved by the FDA in June

      Bridget Hoyt
      July 2nd 2025
      Article

      Oncologic therapies approved in June included indications in genitourinary, lung, and hematologic, and head and neck cancers.


      The Vitals

      Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

      Lindsay Fischer
      December 14th 2023
      Podcast

      Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.


      Graphic of a pair of lungs with tumors

      ICI Rechallenge With Anlotinib May Benefit Pretreated ES-SCLC

      Roman Fabbricatore
      July 1st 2025
      Article

      Anlotinib combined with immune checkpoint inhibitors may benefit patients with extensive-stage small cell lung cancer treated with prior immunotherapy.


      Photo of a woman with brown hair and bangs, surrounded by a blue border

      AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

      Michelle Kirschner, RN, MSN, ACNP, APRN-BC
      June 30th 2025
      Article

      Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.

      Latest Conference Coverage

      Allogenic CAR T-Cell Agent Safe, Active in Heavily Pretreated RCC

      No Survival, Recurrence Benefit With Aspirin in CRC Liver Metastases

      Relacorilant Combo Sustains Ovarian Cancer Benefit Post Platinum Break

      Genomic Changes May Drive Sotorasib KRAS G12C+ Combo Resistance in CRC

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.